CRM AI Stock Analysis – Buy, Hold, or Avoid?
Salesforce, Inc. (CRM)
Fundamentals
Salesforce (CRM) demonstrates robust financial health with strong revenue and earnings growth, reflected in consistent margin expansion and improving profitability ratios. The company's solid earnings beats and steady share price recovery from lows indicate healthy execution amid a competitive but expanding cloud software market.
Financial Highlights
- Revenue
- Net Income
- Net Margin (%)
Revenue
13.27% YoY
Q1 2026
Net Income
36.73% YoY
Q1 2026
Net Margin
Q1 2026
Growth Metrics
Revenue Growth YoY
Latest Quarter: Q1 2026
Net Income Growth YoY
Latest Quarter: Q1 2026
Revenue Per Share Growth YoY
Latest Quarter: Q1 2026
EPS Growth YoY
Latest Quarter: Q1 2026
Book Value Per Share Growth YoY
Latest Quarter: Q1 2026
| Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 11.1B | 11.2B | 10.3B | 10.2B | 9.8B | 10.0B | 9.4B | 9.3B |
| Revenue Growth YoY | +13.27% | +12.09% | +8.63% | +9.77% | +7.62% | +7.60% | +8.30% | +8.39% |
| Net Income | 2.1B | 1.9B | 2.1B | 1.9B | 1.5B | 1.7B | 1.5B | 1.4B |
| Net Income Growth YoY | +36.73% | +13.76% | +36.61% | +32.05% | +0.52% | +18.12% | +24.75% | +12.79% |
| EPS | $2.43 | $2.08 | $2.19 | $1.97 | $1.61 | $1.78 | $1.60 | $1.48 |
| EPS Growth YoY | +50.93% | +16.85% | +36.87% | +33.11% | +1.90% | +19.46% | +26.98% | +13.85% |
Profitability Metrics
Technical Analysis
CRM is currently in a technical downtrend as per stage analysis, with price between key moving averages and a weak ADX indicating a lack of strong trend momentum. The stock faces resistance near the 150-day and 200-day SMAs with the short-term 50-day SMA below the 200-day SMA, signaling bearish crossover conditions. Momentum indicators like RSI are neutral, suggesting no immediate overbought or oversold extremes, while volume trends and MACD signals are not indicating strong directional conviction currently.
No extreme reading
Mixed signals
Range-bound market
Watching for cross
Key Technical Values
Price with Moving Averages
50-day, 150-day and 200-day simple moving averages
Relative Strength Index
Momentum oscillator measuring speed and magnitude of price changes
RSI (14)
Earnings
Salesforce (CRM) demonstrates robust financial health with strong revenue and earnings growth, reflected in consistent margin expansion and improving profitability ratios. The company's solid earnings beats and steady share price recovery from lows indicate healthy execution amid a competitive but expanding cloud software market.
Latest Earnings
Q1 2026 Earnings (Apr 30, 2026)
Earnings Per Share (EPS)
Actual
$3.88
Estimated
$3.13
Surprise
+$0.75
Surprise %
+23.96%
Revenue
Actual
$11.13B
Estimated
$11.05B
Surprise
+$79.73M
Surprise %
+0.72%
Historical Earnings
| Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | |
|---|---|---|---|---|---|---|---|---|
| Earnings Per Share | ||||||||
| EPS (Actual) | $3.88 | $3.81 | $3.25 | $2.91 | $2.58 | $2.78 | $2.41 | $2.56 |
| EPS (Estimated) | $3.13 | $3.05 | $2.86 | $2.78 | $2.55 | $2.61 | $2.44 | $2.35 |
| EPS Surprise | +$0.75 | +$0.76 | +$0.39 | +$0.13 | +$0.03 | +$0.17 | -$0.03 | +$0.21 |
| % Diff | +24.0% | +24.9% | +13.6% | +4.7% | +1.2% | +6.5% | -1.2% | +8.9% |
| Revenue | ||||||||
| Revenue (Actual) | $11.13B | $11.2B | $10.26B | $10.24B | $9.83B | $9.99B | $9.44B | $9.33B |
| Revenue (Estimated) | $11.05B | $11.19B | $10.27B | $10.14B | $9.76B | $10.04B | $9.37B | $9.22B |
| Revenue Surprise | +$79.73M | +$9.09M | -$15.25M | +$95.65M | +$72.77M | -$47.24M | +$76.82M | +$105.91M |
| % Diff | +0.7% | +0.1% | -0.1% | +0.9% | +0.7% | -0.5% | +0.8% | +1.1% |
Valuation
Salesforce (CRM) currently trades at valuation multiples significantly lower than its own historical highs and well below the broader software sector averages, reflecting a meaningful discount. Analyst consensus is cautiously optimistic with a "Moderate Buy" rating and price targets suggesting upside potential around 35% to 40%. The company demonstrates solid financial metrics, supported by strong operating margins and healthy revenue and earnings growth, though liquidity ratios and debt levels warrant monitoring.
Valuation Metrics
Price to Earnings
TTM
Price to Sales
TTM
Price to Book
TTM
Enterprise Value to EBITDA
TTM
Enterprise Value to Revenue
TTM
| Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | |
|---|---|---|---|---|---|---|---|---|
| Price to Earnings | 18.16 | 25.52 | 29.73 | 32.78 | 41.73 | 47.99 | 45.53 | 43.72 |
| Price to Sales | 13.76 | 17.72 | 24.24 | 24.13 | 26.50 | 32.79 | 29.71 | 26.75 |
| Price to Book | 4.48 | 3.36 | 4.14 | 4.03 | 4.29 | 5.36 | 4.79 | 4.33 |
| Enterprise Value to EBITDA | 46.28 | 55.59 | 83.48 | 76.90 | 94.90 | 110.26 | 102.79 | 90.78 |
| Enterprise Value to Revenue | 16.72 | 18.60 | 24.45 | 24.21 | 26.54 | 33.05 | 30.07 | 27.15 |
Sentiment & Analyst Ratings
Salesforce (CRM) currently experiences a cautiously optimistic market sentiment amid strong AI-driven product traction and significant government contracts. Analyst consensus remains moderately positive with a majority recommending buy or hold, tempered by some concerns over demand slowdown and competitive pressures. Recent stock gains alongside upbeat quarterly results reflect renewed investor confidence but with prudent valuation adjustments evident.
Analyst Recommendations
Risk Assessment
Salesforce exhibits moderate financial risk characterized by a highly leveraged balance sheet and liquidity levels below conventional comfort thresholds, reflecting increased short-term financial obligations. While its strong market position and growing AI-driven revenue streams indicate growth potential, competition, rising costs, and operational complexities raise concerns about sustainable profitability. Investors should weigh these risks against robust demand and strategic AI integration when considering investment.
Liquidity & Solvency
Frequently Asked Questions about CRM
AI Answers: Common Questions About CRM
Get AI-powered answers to the questions investors ask most about Salesforce, Inc.
Yes, Salesforce trades at a P/E of 13.29, well below its historical highs and sector averages, with strong revenue growth (~10-13% YoY) and expanding margins, indicating a good buying opportunity especially for medium to long-term investors.
Not currently. Despite short-term technical weakness and mixed sentiment, fundamentals and valuation support holding or buying. Selling might be considered if liquidity worsens or competitive pressures significantly erode margins.
Key risks include high leverage with a debt-to-equity ratio above 1.2, liquidity pressures (current ratio below 1), intense competition from cloud and AI providers, and uncertainties in AI product monetization and regulatory environment.
Analyst consensus price targets average around $245, implying upside potential of approximately 35% from the current price of $184.02, supported by strong earnings beats and AI-driven growth.
The stock is undervalued with a P/E of 13.29 and EV/EBITDA multiples below sector averages, reflecting market caution but offering a value entry point given Salesforce's robust profitability and growth trajectory.
Salesforce shows strong fundamentals with $41.5 billion revenue in FY2025, 77% gross margins, 36% EBITDA margin in Q1 FY2026, and net income doubling to $7.5 billion, driven by organic growth and innovation.
Technically, the stock is in a bearish medium-term downtrend with a death cross and weak trend momentum, consolidating between $170 and $190. Short-term momentum is neutral, suggesting range-bound trading.
Upcoming catalysts include AI product rollouts, expansion of government contracts like the $1.6 billion VA deal, and continued earnings growth, which could drive sentiment and price appreciation.
Want a Personalized Answer?
Get AI-powered insights tailored to your risk tolerance and investment goals.